These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7191225)

  • 1. Halothane-induced suppression of cell-mediated immunity in normal and tumor-bearing C3Hf/He mice.
    Lewis RE; Cruse JM; Hazelwood J
    Anesth Analg; 1980 Sep; 59(9):666-71. PubMed ID: 7191225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor.
    Martin WJ; Esber E; Cotton WG; Rice JM
    J Immunol; 1975 Jul; 115(1):289-295. PubMed ID: 50354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipocortin I in macrophage-mediated immunosuppression in tumor-bearing mice.
    Sakata T; Iwagami S; Tsuruta Y; Teraoka H; Hojo K; Suzuki S; Sato K; Suzuki R
    J Immunol; 1990 Jul; 145(1):387-96. PubMed ID: 2141618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth of allogeneic sarcoma in mice subjected to halothane anesthesia and/or surgical stress.
    Radosević-Stasić B; Udović-Sirola M; Stojanov L; Ribarić L; Rukavina D
    Anesth Analg; 1989 Nov; 69(5):570-4. PubMed ID: 2802192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for interaction between T cell populations of tumor-bearing and normal mice in immune suppression.
    Ingenito GG; Calkins CE
    J Immunol; 1981 Sep; 127(3):1236-40. PubMed ID: 6455472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression associated with SJL/J murine lymphoma. I. Suppression of cell-mediated immune responses after tumor transplantation.
    Kumar RK; Lykke AW; Penny R
    J Natl Cancer Inst; 1981 Dec; 67(6):1269-75. PubMed ID: 6458725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.
    Tzai TS; Lin JS; Chow NH
    J Surg Res; 1996 Oct; 65(2):139-44. PubMed ID: 8903460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive phenomena in experimental tumor systems (author's transl)].
    Reme TX
    Pathol Biol (Paris); 1977 Dec; 25(10):735-40. PubMed ID: 349487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity.
    Bonventre PF; Nickol AD; Ball EJ; Michael JG; Bubel HC
    J Reticuloendothel Soc; 1982 Jul; 32(1):25-35. PubMed ID: 6290658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression.
    Kurzawa H; Wysocka M; Aruga E; Chang AE; Trinchieri G; Lee WM
    Cancer Res; 1998 Feb; 58(3):491-9. PubMed ID: 9458095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of surface immunoglobulin-bearing cells, plasma cells, and tumor development in anaplastic carcinoma-bearing A/J mice.
    Chi DS; Harris NS
    Cancer Res; 1977 Apr; 37(4):1119-24. PubMed ID: 300278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
    Cao X; Wang Q; Ju DW; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of progressive neoplastic growth on the decarboxylation of DL-[1-14C]ornithine by lymphocytes from C3H/He tumor hosts.
    Vaage J; Agarwal S; Reinertsen JL
    Cancer Res; 1978 Aug; 38(8):2253-8. PubMed ID: 667820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of immune response to sheep red blood cells in mice treated with preparations of a tumor cell component and in tumor-bearing mice.
    Pikovski MA; Ziffroni-Gallon Y; Witz IP
    Eur J Immunol; 1976 Jul; 5(7):447-50. PubMed ID: 1086244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor.
    Brodt P; Gordon J
    J Immunol; 1978 Jul; 121(1):359-62. PubMed ID: 307580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiabendazole: a potential adjuvant in cancer therapy.
    Lundy J; Lovett EJ; Conran P; Goldblatt PJ
    Surgery; 1976 Nov; 80(5):636-40. PubMed ID: 982282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in mice.
    Ben-Hur H; Ben-Meir A; Hagay Z; Ben-Meir A; Berman V; Schwartsburd B; Gurevich P; Sandler B; Tendler Y; Zinder O; Zusman I
    Anticancer Res; 1998; 18(6A):4237-41. PubMed ID: 9891473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor cell activity in tumor-bearing mice. II. Inhibition of DNA synthesis and DNA polymerases by TBH splenic suppressor cells.
    Farrar WL; Elgert KD
    J Immunol; 1978 Apr; 120(4):1354-61. PubMed ID: 305940
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunomodulating effects of halothane in mice.
    Atallah MM; Motawea AA; el-Chennawy FA; Attallah AF
    Eur J Anaesthesiol; 1991 May; 8(3):239-44. PubMed ID: 1874221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.